Trademark search
15 results for of record for one firm.
| Mark | Status | Office | Owner | Classes | Filed |
|---|---|---|---|---|---|
| DEGSETVY | examining | USPTO | Astellas Pharma Inc. | 5 | 2026-10-13 |
| KRASREMO | examining | USPTO | Astellas Pharma Inc. | 5 | 2026-10-13 |
| KRASIGDA | examining | USPTO | Astellas Pharma Inc. | 5 | 2026-10-13 |
| KRASMYDA | examining | USPTO | Astellas Pharma Inc. | 5 | 2026-10-13 |
| XTANDI TODAY TO HELP EXTEND TOMORROW | examining | USPTO | Astellas Pharma Inc. | 44 | 2026-10-07 |
| [Design Mark] | examining | USPTO | Astellas Pharma Inc. | 44 | 2026-10-05 |
| VISSA-GA | examining | USPTO | Astellas Institute for Regenerative Medicine | 9, 16, 42 | 2026-09-21 |
| VISSA-STGD | examining | USPTO | Astellas Institute for Regenerative Medicine | 9, 16, 42 | 2026-09-21 |
| DISPEL | examining | USPTO | Astellas Pharma Inc. | 44 | 2026-09-09 |
| CELLAFA PRDMO | examining | USPTO | Cellafa Bioscience Inc. | 40, 42, 44 | 2026-06-16 |
| POMPE TOGETHER | registered | USPTO | Astellas Gene Therapies, Inc. | 44 | 2026-02-09 |
| POMPE TOGETHER | registered | USPTO | Astellas Gene Therapies, Inc. | 44 | 2026-02-09 |
| ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE | registered | USPTO | Astellas Institute for Regenerative Medicine | 42, 44 | 2016-05-10 |
| XTANDI SUPPORT SOLUTIONS (ENZALUTAMIDE) 40 MG CAPSULES | registered | USPTO | Astellas US LLC | 16 | 2015-02-03 |
| ASTELLAS CARES | registered | USPTO | Astellas US LLC | 9, 16, 36, 44 | 2014-09-04 |